Project measures / variables set:   Wiltshire2   fluoxetine

ID, description, units MPD:38007   fluoxetine   drug and metabolite concentration   [ng/mL]  
fluoxetine study
Measures
• fluoxetine    • norfluoxetine
Data set, strains Wiltshire2   inbred   30 strains     sex: m     age: 10-11wks
Procedure drug and metabolite quantification
Comparisoncontrol group vs. treated group
Ontology mappings

  SIDE-BY-SIDE STRAIN CURVES
Values
Graph Type
Dimensions Width:  ×  Height: px
Plot Options


  OVERLAPPING STRAIN CURVES
Data
Dimensions px
Toggle Series   
Plot Options
Advanced Plot Options
Separate Plot Factor(s)
Legend Factor(s)
X-Axis Factor(s)
Include/Exclude Factor Values

Wiltshire2 - drug and metabolite concentration




  ANOVA, Q-Q NORMALITY ASSESSMENT

ANOVA Summary     

Factor DF Sum of squares Mean sum of squares F value p-value (Pr>F)
group 1 499128.5204 499128.5204 3.1229 0.0777
strain 29 56067533.7493 1933363.2327 12.0965 < 0.0001
group:strain 29 8147029.6602 280932.0572 1.7577 0.0089
Residuals 618 98773825.5863 159828.1967

Q-Q normality assessment based on residuals

  


  INDIVIDUAL MEASURES
ProjectIDTreatmentMeasure / Variable Description PanelStrains
tested
SexAge
Wiltshire2 38007 drug and metabolite quantification fluoxetine drug and metabolite concentration   [ng/mL]   fluoxetine  fluoxetine inbred 30 m 10-11wks
Wiltshire2 38008 drug and metabolite quantification fluoxetine drug and metabolite concentration   [ng/mL]   norfluoxetine  norfluoxetine inbred 30 m 10-11wks